A trailblazer in pharmacy and the life sciences, the University is harnessing its expertise in these fields and building on its past success by creating the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) - a pioneering, world-class centre for teaching and research, with a particular focus on drug discovery and development.
The new Institute will drive forward the search for new drugs to treat major diseases such as cancers, cardiovascular disease, psychiatric and inflammatory conditions as well as infectious diseases.
A new purpose-built building is required that will attract leading scientists to Glasgow, bring research groups together, facilitate more and better interaction with industry, produce more numerous technologies for exploitation, make easier the creative cross disciplinary collaborations on which successful future drug discovery depends and improve facilities for both students and staff.
The University will inject £28m into the £36m capital build - its largest investment in a single project to date. We have already secured lead gifts of £2.75m from charitable trusts such as the Wolfson Foundation, the Robertson Trust and the Garfield Weston Foundation, and the balance will be raised through a campaign for philanthropic support.